Complete Filing Data
Immix Biopharma, Inc. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations of $93.93 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Immix Biopharma, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$29.4M | -$21.6M | -$15.4M | -$8.2M | -$24.4M | -$1.1M |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $61.2K | -$135.7K | $47.6K | -$38.4K | -$6.5K | $63.6K |
| Research And Development Expense | $16.3M | $11.3M | $8.7M | $4.2M | $126.5K | $248.1K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $61.2K | -$135.7K | $47.6K | -$38.4K | -$6.5K | $63.6K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $61.2K | -$135.7K | $47.6K | -$38.4K | -$6.5K | $63.6K |
| Operating Income Loss | -$30.0M | -$22.7M | -$16.1M | -$8.2M | -$1.4M | -$453.9K |
| Operating Expenses | $30.0M | $22.7M | $16.1M | $8.2M | $1.4M | $453.9K |
| Income Tax Expense Benefit | $37.7K | $41.0K | $26.4K | $10.3K | $6.0K | $17.5K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$29.4M | -$21.7M | -$15.6M | -$8.2M | -$24.4M | -$1.1M |
| General And Administrative Expense | $13.7M | $11.4M | $7.4M | $4.0M | $1.2M | $205.7K |
| Nonoperating Income Expense | $555.5K | $1.0M | $572.0K | -$497.00 | -$23.0M | -$676.5K |
| Comprehensive Income Net Of Tax | -$21.7M | -$15.4M | -$8.3M | -$24.4M | -$1.1M | |
| Income Tax Receivable | $2.0M | $1.2M | $255.7K | $25.7K | $127.4K | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$29.4M | -$21.7M | -$15.4M | |||
| Net Income Loss Attributable To Noncontrolling Interest | -$85.0K | -$169.5K | ||||
| Interest Expense | $497.00 | $179.9K | $102.0K | |||
| Income Taxes Paid Net | $17.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$7.6M | -$6.6M | -$4.5M | -$7.1M | -$4.4M | -$5.3M | -$4.3M | -$3.6M | -$2.5M | -$1.5M | -$1.6M | -$1.3M | -$403.3K | -$208.6K | -$1.0M |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$2.6K | $49.6K | $16.5K | $75.1K | $27.4K | -$45.1K | -$34.1K | -$1.7K | -$4.5K | -$40.4K | -$38.6K | $15.6K | -$3.5K | $4.7K | -$9.2K |
| Research And Development Expense | $4.6M | $4.0M | $2.0M | $4.4M | $2.2M | $3.2M | $2.1M | $2.2M | $1.3M | $695.9K | $607.8K | $629.5K | $29.7K | $62.8K | $24.8K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$2.6K | $49.6K | $16.5K | $75.1K | $27.4K | -$45.1K | -$34.1K | -$1.7K | -$4.5K | -$40.4K | -$38.6K | $15.6K | -$3.5K | $4.7K | -$9.2K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$2.6K | $49.6K | $16.5K | $75.1K | $27.4K | -$45.1K | -$34.1K | -$1.7K | -$4.5K | -$40.4K | -$38.6K | $15.6K | -$3.5K | $4.7K | -$9.2K |
| Operating Income Loss | -$7.7M | -$6.7M | -$4.7M | -$7.4M | -$4.7M | -$5.6M | -$4.5M | -$3.7M | -$2.5M | -$1.5M | -$1.6M | -$1.3M | -$348.0K | -$243.2K | -$162.5K |
| Operating Expenses | $7.7M | $6.7M | $4.7M | $7.4M | $4.7M | $5.6M | $4.5M | $3.7M | $2.5M | $1.5M | $1.6M | $1.3M | $348.0K | $243.2K | $162.5K |
| Income Tax Expense Benefit | $7.7K | $8.9K | $9.8K | $11.1K | $10.3K | $8.8K | $6.8K | $6.3K | $5.2K | $1.7K | $1.7K | $1.6K | $1.3K | $1.6K | $1.6K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$7.6M | -$6.6M | -$4.5M | -$7.1M | -$4.4M | -$5.3M | -$4.3M | -$3.6M | -$2.5M | -$1.5M | -$1.6M | -$1.3M | -$401.9K | -$207.0K | -$1.0M |
| General And Administrative Expense | $3.1M | $2.7M | $2.7M | $2.9M | $2.5M | $2.3M | $2.4M | $1.5M | $1.2M | $837.4K | $953.2K | $700.5K | $318.3K | $180.4K | $137.7K |
| Nonoperating Income Expense | $84.5K | $104.1K | $150.2K | $256.7K | $306.9K | $267.9K | $186.7K | $128.8K | $27.9K | -$109.00 | -$388.00 | -$53.9K | -$36.1K | -$852.5K | |
| Comprehensive Income Net Of Tax | -$7.1M | -$4.4M | -$5.3M | -$4.3M | -$3.6M | -$2.5M | -$1.6M | -$1.6M | -$1.3M | -$406.8K | -$203.9K | -$1.0M | |||
| Income Tax Receivable | $2.0M | $2.0M | $2.0M | $652.5K | $297.0K | $322.4K | $182.3K | $165.0K | $63.7K | ||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$7.6M | -$6.6M | -$4.5M | -$7.1M | -$4.4M | -$5.3M | -$4.3M | -$3.6M | -$2.5M | ||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$12.9K | -$72.1K | -$63.2K | -$22.0K | -$18.4K | ||||||||||
| Interest Expense | $109.00 | $388.00 | $53.9K | $53.9K | $27.5K | ||||||||||
| Income Taxes Paid Net | $9.8K | $8.8K | $5.2K | $1.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $93.8M | $13.3M | $16.4M | $13.2M | $18.0M | -$4.7M | -$3.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $93.9M | $17.7M | $17.5M | $13.4M | $17.6M | $391.1K | $734.0K |
| Property Plant And Equipment Net | $2.5M | $1.7M | $50.2K | $3.6K | $5.7K | $7.4K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $76.2M | $172.2K | $4.1M | -$4.2M | $17.3M | -$342.9K | |
| Retained Earnings Accumulated Deficit | -$104.5M | -$75.0M | -$53.4M | -$38.0M | -$29.8M | -$5.4M | |
| Prepaid Expense And Other Assets Current | $828.3K | $541.5K | $1.1M | $1.2M | $516.2K | $13.7K | |
| Liabilities Current | $10.1M | $8.7M | $3.7M | $1.3M | $202.0K | $5.3M | |
| Liabilities And Stockholders Equity | $104.8M | $22.9M | $19.9M | $14.9M | $18.2M | $539.6K | |
| Liabilities | $11.0M | $9.7M | $3.7M | $1.7M | $202.0K | $5.3M | |
| Common Stock Value | $5.3K | $2.8K | $2.0K | $1.4K | $1.3K | $338.00 | |
| Cash And Cash Equivalents At Carrying Value | $93.9M | $17.7M | $17.5M | $13.4M | $17.6M | $391.1K | |
| Assets Current | $101.2M | $20.2M | $19.8M | $14.9M | $18.2M | $532.2K | |
| Assets | $104.8M | $22.9M | $19.9M | $14.9M | $18.2M | $539.6K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $60.2K | -$1.1K | $134.7K | $87.0K | $125.4K | $131.9K | |
| Accounts Payable And Accrued Liabilities Current | $10.0M | $8.6M | $3.7M | $1.3M | $142.9K | $252.3K | |
| Treasury Stock Common Shares | 72.4K | 72.4K | 72.4K | 72.4K | |||
| Stock Issued During Period Value Under Atm Facilities For Cash Proceeds Net Of Offering Costs | $4.4M | $338.5K | $5.4M | ||||
| Other Assets Noncurrent | $20.4K | $20.4K | |||||
| Deferred Offering Costs Charged Against Proceeds From Sale Of Common Stock | $43.4K | $87.2K | $147.4K | ||||
| Treasury Stock Value | $100.0K | $100.0K | $100.0K | ||||
| Operating Lease Right Of Use Asset | $966.9K | $989.5K | |||||
| Operating Lease Liability Noncurrent | $933.6K | $1.0M | |||||
| Operating Lease Liability Current | $139.3K | $65.2K | |||||
| Finance Lease Right Of Use Asset Amortization | $118.8K | $82.4K | |||||
| Right Of Use Asset And Liabilities | $96.2K | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $8.3M | $4.7M | $9.6M | $17.6M | $23.9M | $27.9M | $19.8M | $13.2M | $11.8M | $16.7M | $18.1M | $19.7M | $18.0M | -$6.2M | -$5.9M | -$5.7M | -$4.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $15.9M | $11.6M | $15.9M | $19.7M | $24.0M | $29.3M | $19.6M | $12.7M | $11.5M | $16.9M | $18.4M | $19.1M | $38.0K | $110.6K | $180.8K | |||
| Property Plant And Equipment Net | $2.4M | $2.2M | $2.1M | $1.4M | $454.0K | $360.8K | $40.1K | $2.5K | $50.2K | $4.1K | $4.7K | $5.1K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.8M | $11.8M | -$2.0M | $1.4M | -$210.3K | |||||||||||||
| Retained Earnings Accumulated Deficit | -$93.8M | -$86.2M | -$79.6M | -$70.2M | -$63.1M | -$58.7M | -$48.3M | -$44.0M | -$40.5M | -$34.2M | -$32.7M | -$31.1M | ||||||
| Prepaid Expense And Other Assets Current | $637.0K | $687.5K | $858.1K | $1.1M | $1.4M | $1.6M | $2.1M | $2.6M | $1.2M | $292.0K | $515.9K | $888.0K | ||||||
| Liabilities Current | $10.9M | $10.0M | $9.3M | $6.6M | $3.9M | $5.7M | $2.8M | $2.4M | $1.5M | $646.5K | $977.2K | $365.1K | ||||||
| Liabilities And Stockholders Equity | $20.1M | $15.6M | $19.9M | $25.1M | $28.8M | $34.3M | $22.5M | $15.6M | $13.2M | $17.4M | $19.1M | $20.0M | ||||||
| Liabilities | $11.8M | $11.0M | $10.3M | $7.6M | $4.9M | $6.7M | $2.8M | $2.4M | $1.5M | $646.5K | $977.2K | $365.1K | ||||||
| Common Stock Value | $3.3K | $2.8K | $2.8K | $2.8K | $2.8K | $2.6K | $2.0K | $1.6K | $1.4K | $1.4K | $1.4K | $1.4K | ||||||
| Cash And Cash Equivalents At Carrying Value | $15.9M | $11.6M | $15.9M | $19.7M | $24.0M | $29.3M | $19.6M | $12.7M | $11.5M | $16.9M | $18.4M | $19.1M | ||||||
| Assets Current | $16.6M | $12.3M | $16.8M | $22.8M | $27.3M | $32.9M | $22.3M | $15.5M | $13.0M | $17.4M | $19.1M | $20.0M | ||||||
| Assets | $20.1M | $15.6M | $19.9M | $25.1M | $28.8M | $34.3M | $22.5M | $15.6M | $13.2M | $17.4M | $19.1M | $20.0M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $62.5K | $65.0K | $15.5K | $192.1K | $117.0K | $89.6K | $46.7K | $80.9K | $82.5K | $62.1K | $102.4K | $141.0K | ||||||
| Accounts Payable And Accrued Liabilities Current | $10.7M | $9.9M | $9.2M | $6.5M | $3.9M | $5.6M | $2.8M | $2.4M | $1.5M | $646.5K | $977.2K | $305.7K | ||||||
| Treasury Stock Common Shares | 72.4K | 72.4K | 72.4K | 72.4K | 72.4K | 72.4K | 72.4K | 72.4K | 72.4K | |||||||||
| Stock Issued During Period Value Under Atm Facilities For Cash Proceeds Net Of Offering Costs | $1.5M | $1.1M | $338.5K | $185.3K | $4.6M | $101.3K | ||||||||||||
| Other Assets Noncurrent | $20.4K | $20.4K | $20.4K | $20.4K | $20.4K | $20.4K | $103.2K | $56.7K | $175.1K | $6.7K | ||||||||
| Deferred Offering Costs Charged Against Proceeds From Sale Of Common Stock | $87.2K | $2.6K | ||||||||||||||||
| Treasury Stock Value | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $56.0K | $56.0K | ||||||||||
| Operating Lease Right Of Use Asset | $1.0M | $947.1K | $968.4K | $1.0M | $1.0M | $1.1M | ||||||||||||
| Operating Lease Liability Noncurrent | $965.1K | $972.3K | $991.1K | $1.0M | $1.0M | $1.1M | ||||||||||||
| Operating Lease Liability Current | $141.3K | $70.5K | $67.8K | $62.7K | $48.4K | $34.3K | ||||||||||||
| Finance Lease Right Of Use Asset Amortization | $21.0K | $20.8K | ||||||||||||||||
| Right Of Use Asset And Liabilities | $1.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $2.4M | $1.9M | $524.1K | $219.0K | ||
| Proceeds From Issuance Of Common Stock | $107.4M | $15.9M | $15.5M | $2.9M | $18.6M | |
| Net Cash Provided By Used In Operating Activities | -$23.9M | -$14.6M | -$11.4M | -$7.4M | -$1.6M | -$404.7K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $286.7K | -$554.8K | -$111.8K | $691.0K | $502.8K | -$10.1K |
| Increase Decrease In Income Taxes Receivable | -$2.1M | $971.5K | $893.4K | $236.4K | -$97.7K | -$58.5K |
| Share Based Compensation | $2.4M | $3.0M | $2.6M | $624.1K | $219.0K | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.8K | -$3.6K | $33.1K | -$31.5K | -$5.4K | |
| Net Cash Provided By Used In Financing Activities | $107.4M | $15.9M | $15.5M | $3.2M | $18.8M | |
| Payments To Acquire Property Plant And Equipment | $732.9K | $1.2M | $52.1K | $802.00 | ||
| Net Cash Provided By Used In Investing Activities | -$7.2M | -$1.2M | -$52.1K | -$802.00 | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.4M | $1.1M | -$106.1K | -$3.8K | ||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $1.0M | $4.4M | $2.4M | |||
| Increase Decrease In Interest Payable Net | -$9.1K | $120.2K | $101.1K | |||
| Increase Decrease In Operating Lease Liability | -$98.0K | $2.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $602.1K | $628.8K | $535.4K | $615.9K | $737.3K | $447.7K | $329.9K | $163.2K | $65.7K | $65.1K | $61.9K | $30.7K | $4.2K |
| Proceeds From Issuance Of Common Stock | $15.9M | $103.9K | $2.9M | ||||||||||
| Net Cash Provided By Used In Operating Activities | -$1.7M | -$3.8M | -$2.1M | -$1.5M | -$266.4K | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $316.6K | $477.0K | $43.0K | $353.7K | -$293.00 | ||||||||
| Increase Decrease In Income Taxes Receivable | -$2.0M | $911.5K | $72.2K | $36.0K | $25.5K | ||||||||
| Share Based Compensation | $868.4K | $943.3K | $329.9K | $65.1K | $4.2K | ||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$8.0K | -$10.4K | -$562.00 | -$2.7K | -$8.0K | ||||||||
| Net Cash Provided By Used In Financing Activities | $15.9M | $118.9K | $2.9M | $65.0K | |||||||||
| Payments To Acquire Property Plant And Equipment | $67.7K | $301.9K | $802.00 | ||||||||||
| Net Cash Provided By Used In Investing Activities | -$67.7K | -$301.9K | -$802.00 | ||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $190.8K | $160.9K | -$142.0K | ||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $258.7K | $1.9M | $190.8K | ||||||||||
| Increase Decrease In Interest Payable Net | $308.00 | $25.9K | |||||||||||
| Increase Decrease In Operating Lease Liability | -$15.8K | $21.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.89 | -$0.76 | -$0.89 | -$0.59 | -$6.64 | -$0.34 |
| Weighted Average Number Of Shares Outstanding Basic | 33.0M | 28.3M | 17.3M | 13.9M | 3.7M | |
| Earnings Per Share Basic | $-0.89 | $-0.76 | $-0.89 | $-0.59 | $-6.64 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Common Stock Shares Outstanding | 53.0M | 27.5M | 19.9M | 13.9M | 13.2M | 3.4M |
| Common Stock Shares Issued | 53.0M | 27.6M | 20.0M | 14.0M | 13.2M | 3.4M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 20.0M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Diluted Shares Outstanding | 33.0M | 28.3M | 17.3M | 13.9M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.24 | -$0.22 | -$0.15 | -$0.24 | -$0.15 | -$0.22 | -$0.23 | -$0.24 | -$0.18 | -$0.11 | -$0.11 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 31.9M | 30.0M | 29.7M | 29.4M | 28.8M | 23.4M | 18.6M | 15.0M | 13.9M | 13.9M | 13.9M | 13.8M | 3.4M | 3.4M | 3.4M |
| Earnings Per Share Basic | $-0.24 | $-0.22 | $-0.15 | $-0.24 | $-0.15 | $-0.22 | $-0.23 | $-0.24 | $-0.18 | $-0.11 | $-0.11 | $-0.10 | $-0.12 | $-0.06 | $-0.30 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Common Stock Shares Outstanding | 33.0M | 28.4M | 27.9M | 27.5M | 27.4M | 26.4M | 19.6M | 16.3M | 13.9M | 13.9M | 13.9M | 13.9M | |||
| Common Stock Shares Issued | 33.1M | 28.5M | 27.9M | 27.6M | 27.5M | 26.5M | 19.7M | 16.3M | 14.0M | 14.0M | 13.9M | 13.9M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 31.9M | 30.0M | 29.7M | 29.4M | 28.8M | 23.4M | 18.6M | 15.0M | 13.9M | 13.9M | 13.9M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation | $245.7K | $32.9K | $5.5K | $2.1K | $2.5K | $2.3K |
| Additional Paid In Capital | $198.3M | $88.4M | $69.8M | $51.2M | $47.6M | $508.9K |
| Stock Issued During Period Value Issued For Services | $508.8K | $627.4K | $622.4K | $100.0K | ||
| Investment Income Interest | $555.5K | $1.0M | $572.0K | |||
| Stock Issued During Period Value New Issues | $93.7M | $15.5M | $2.9M | $18.6M | ||
| Payment Of Financing And Stock Issuance Costs | $137.0K | $234.6K | $6.7K | |||
| Stock Issued During Period Value Stock Options Exercised | $6.3K | $2.5K | $2.6K | |||
| Stock Issued During Period Shares Stock Options Exercised | 4.9K | 834.00 | 1.4K | 141.0K | ||
| Interest Paid Net | $9.6K | $1.5K | $899.00 | |||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.9M | $2.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | $38.2K | $3.0K | $505.00 | $620.00 | $608.00 | ||||||||
| Additional Paid In Capital | $102.1M | $90.9M | $89.2M | $87.7M | $86.9M | $86.6M | $68.1M | $57.3M | $52.3M | $50.9M | $50.7M | $50.6M | |
| Stock Issued During Period Value Issued For Services | $67.5K | $67.5K | $266.3K | $105.0K | $102.5K | $327.4K | $50.0K | $50.0K | |||||
| Investment Income Interest | $84.5K | $104.1K | $150.2K | $256.7K | $306.9K | $267.9K | $186.7K | $128.8K | $27.9K | ||||
| Stock Issued During Period Value New Issues | $15.5M | $2.9M | |||||||||||
| Payment Of Financing And Stock Issuance Costs | $160.0K | $35.0K | |||||||||||
| Stock Issued During Period Value Stock Options Exercised | $516.00 | $5.8K | $2.5K | ||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 1.3K | ||||||||||||
| Interest Paid Net | $80.00 | ||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $403.0K | $464.7K | $602.1K | $628.8K | $535.4K | $615.9K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.